Skip to main content
. 2017 Apr 21;22(3):217–222. doi: 10.1016/j.rpor.2017.01.002

Table 2.

Changes of QoL, anxiety and depression parameters level (median %, in brackets standard deviation). Friedman (X2) ANOVA test used for statistical analysis.

Before SABR 2 w. after 14 w. after p value Change
QLQ-C30
 Global health 58.5 (18.9) 63 (17) 64 (17.5) 0.025
 Physical functioning 66 (21.5) 70.2 (19.6) 73 (16.9) 0.032
 Role functioning 84 (27.1) 87.2 (21.8) 86.3 (25) 0.82
 Emotional functioning 73.7 (24.8) 78.9 (50) 82.7 (21) 0.0003
 Cognitive functioning 80.7 (22.7) 82.9 (22.7) 84.6 (20.3) 0.14
 Social functioning 79.9 (21) 83.3 (19.9) 85 (18) 0.15
 Fatigue 32 (28.9) 31.1 (25.6) 25.3 (18.9) 0.49
 Nausea 1.3 (4.5) 2.5 (6.1) 0.8 (3.7) 0.23
 Pain 23.1 (26) 17.9 (24.3) 15.8 (20.9) 0.18
 Dyspnea 33.3 (32.4) 29.1 (28.8) 28.2 (25.9) 0.27
 Insomnia 40.2 (33.5) 26.5 (33.5) 23.9 (28.5) 0.003
 Appetite loss 18.8 (26.3) 18.8 (30) 11.1 (20.7) 0.03
 Constipation 27.3 (33.2) 19.6 (30.2) 12.9 (23.7) 0.002
 Diarrhea 1.7 (7.4) 1.7 (7.4) 2.5 (8.9) 0.71
 Financial problems 17.1 (26) 14.5 (22.7) 14.5 (18.4) 0.91
QLQ-LC13
 Dyspnea 37.0 (25) 33.0 (25) 32.0 (23.2) 0.027 –/↓
 Coughing 35.8 (27.6) 37.0 (29.1) 29.1 (24.1) 0.19
 Hemoptysis 0.8 (5.2) 1.6 (7.3) 0.0 (NA) NA
 Sore mouth 5.8 (19.1) 5.8 (17) 0.0 (NA) 0.06
 Dysphagia 8.3 (19.6) 7.5 (22) 6.7 (21) 0.25
 Neuropathy 24.1 (29) 20.1 (29) 23.3 (26) 0.50
 Alopecia 15.8 (30.1) 5.8 (21.2) 7.5 (20.6) 0.06
 Pain in chest 19.1 (26.3) 15.0 (22.6) 15.0 (16.7) 0.41
 Pain arm 24.2 (30.1) 14.2 (22.5) 14.2 (22.5) 0.02 –/↓
 Pain in other 23.3 (31.3) 21.7 (24.5) 15.9 (26.1) 0.19
HAD-S
 Anxiety 4.8 (4.5) 3.6 (3.5) 3.3 (3.4) 0.0063
 Depression 4.5 (3.7) 3.0 (3.4) 2.84 (3.6) 0.0016

Bold values indicate statistically significant changes at p < 0.05.